Medicenna Therapeutics Corp. SEC filings MDNAF
Medicenna Therapeutics Corp. has 178 filings in SEC EDGAR's recent list, going back to Mar 30, 2020. Its latest annual report, Form 20-F, was filed on Jun 27, 2023 for the period ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on May 13, 2024. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jul 6, 2026 | — |
| 15-12G | Deregistration | May 14, 2024 | — |
| D | Filing | May 14, 2024 | — |
| EFFECT | Filing | May 13, 2024 | — |
| AW | Form aw | Apr 22, 2024 | — |
| 25-NSE | Delisting notice | Nov 20, 2023 | — |
| EFFECT | Filing | Feb 27, 2023 | — |
| CORRESP | Letter to the SEC | Feb 23, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2023 | — |
| SUPPL | Filing | Aug 10, 2022 | — |
| SUPPL | Filing | Aug 9, 2022 | — |
| SUPPL | Filing | Aug 9, 2022 | — |
| SUPPL | Filing | Dec 30, 2020 | — |
| CERT | Filing | Aug 21, 2020 | — |
| 8-A12B | Filing | Aug 18, 2020 | — |
| EFFECT | Filing | Jul 30, 2020 | — |
| D/A | Filing | Apr 20, 2020 | — |
| D | Filing | Mar 30, 2020 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDNAF (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1807983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.